Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
05/16/2019 05/17/2019 05/20/2019 05/21/2019 05/22/2019 Date
57.29(c) 56.95(c) 55.8(c) 56.07(c) 55.85(c) Last
2 711 328 3 323 031 2 891 319 2 109 780 2 147 331 Volume
+1.49% -0.59% -2.02% +0.48% -0.39% Change
More quotes
Financials (EUR)
Sales 2019 46 541 M
EBIT 2019 8 225 M
Net income 2019 3 674 M
Debt 2019 37 835 M
Yield 2019 5,15%
Sales 2020 48 094 M
EBIT 2020 9 429 M
Net income 2020 4 942 M
Debt 2020 35 210 M
Yield 2020 5,46%
P/E ratio 2019 15,21
P/E ratio 2020 11,93
EV / Sales2019 1,93x
EV / Sales2020 1,81x
Capitalization 52 036 M
More Financials
Company
Bayer is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows: - healthcare products (56.1%): pharmaceutical products (75.4% of net sales; intended for the prevention and treatment of... 
Sector
Pharmaceuticals
Calendar
07/30Earnings Release
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
05/21BAYER : hires law firm to probe Monsanto data collection
RE
05/20BAYER : Collaboration to focus on driving novel technologies and applications fo..
PU
05/15BAYER : Investors Fret Over Roundup Liability
DJ
05/14GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
05/14Materials Up as Trade-War Fears Fade -- Materials Roundup
DJ
05/14Factbox - More Roundup trials, appeals in store for Bayer after $2 billion ve..
RE
05/14NEWS HIGHLIGHTS : Top Company News of the Day
DJ
05/14NEWS HIGHLIGHTS : Top Company News of the Day
DJ
05/14EUROPE MARKETS: Oil, Luxury Goods Drive Rebound For Europe Stocks
DJ
05/14Global Selloff Pauses as European Stocks Post Gains
DJ
More news
Analyst Recommendations on BAYER AG
More recommendations
Stock Trading Strategies
BAYER - 01/07
The beginning of the move
BUY
More Stock Trading Analysis
Sector news : Pharmaceuticals - NEC
05/22DAIICHI SANKYO : looking to sell OTC drug unit for about $900 million - Nikkei B..
RE
05/22JOHNSON & JOHNSON : J&J Unit Gets FDA Priority Review of Invokana in Chronic Kid..
DJ
05/22Synlogic to Study SYNB1891 With Roche's Tecentriq in Advanced Solid Tumors
DJ
05/22AMGEN : to Buy Danish Biotech Nuevolution for $167 Million
DJ
05/22SANOFI : French Deal Spree Fueled By Easy Money
DJ
More sector news : Pharmaceuticals - NEC
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 77,7 €
Spread / Average Target 39%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-7.78%58 036
JOHNSON & JOHNSON7.03%367 513
PFIZER-4.54%231 237
ROCHE HOLDING LTD.9.70%226 519
NOVARTIS12.54%207 417
MERCK AND COMPANY4.04%203 088